Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals, SpectruMedix, MetriGenix, NimbleGen Systems

Premium

Serologicals’ research division Chemicon will launch an OligoDetect assay for SARS. The assays, called Light Diagnostics SARS OligoDetect, use Chemicon’s OligoDetect technology in an ELISA-based colorimetric procedure using a microplate reader.

OligoDetect is a pre-tested kit that takes less than 90 minutes to run. Including sample extraction and amplification, the process typically takes less than three hours, Serologicals said.

The assays will be available as an FDA listed analyte-specific reagent from Chemicon and its worldwide distributor network.


SpectruMedix has launched a service that offers SNP and insertion/deletion discovery, genotyping, assay validation, and kit commercialization. The program will be managed from SpectruMedix’s newly built core lab in the company’s State College, Penn., facility.

Samples will be analyzed using SpectruMedix’s Reveal mutation-analysis system, which is based on temperature-gradient capillary electrophoresis. According to SpectruMedix, Reveal is a non-specific detection method that enables researchers to identify novel mutations or screen for known mutations. This method “also allows sample analysis without prior knowledge of the size or sequence of the amplicon,” SpectruMedix said.

SpectruMedix said it has entered into several collaborative research agreements for specific disease-related clinical research assay kits with industry leaders in disease discovery and screening. The first “clinical research only” kit is expected to be released before the end of the year.


MetriGenix plans before the end of the year to launch the MGX 4D Respiratory Virus Panel Array for research into markers linked to “major viral respiratory agents” like influenza, pneumoviruses, metapneumovirus, corona viruses, mumps, and measles.

The respiratory array, believed to be the first single-chip platform designed to detect these viruses, was developed with researchers at the French Laboratoire de Virologie, and the National WHO Influenza Center. The array, which contains probes to detect known respiratory viral strains, was designed to identify recently emerged influenza subtypes.


NimbleGen Systems has rolled out its human whole-genome oligo-array service. The product comprises almost 200,000 long oligo probes (60mers) with an average coverage of five probes per gene.

 

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.